These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18459462)

  • 61. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
    Abdel-Wahab M; Baev R; Dieker P; Kassner G; Khattab AA; Toelg R; Sulimov D; Geist V; Richardt G
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):285-91. PubMed ID: 22431433
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.
    Wu X; Chen Y; Liu H; Teirstein PS; Kirtane AJ; Ge C; Song X; Chen X; Gu C; Huang F; Lv S
    Am J Cardiol; 2010 Jun; 105(12):1728-34. PubMed ID: 20538122
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
    Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
    J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
    Hannan EL; Racz M; Walford G; Holmes DR; Jones RH; Sharma S; Katz S; King SB
    JACC Cardiovasc Interv; 2008 Apr; 1(2):129-35. PubMed ID: 19463290
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings.
    Lee MS; Yang T; Dhoot J; Liao H
    Am J Cardiol; 2010 Apr; 105(8):1070-5. PubMed ID: 20381655
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.
    Kim YH; Park DW; Ahn JM; Yun SC; Song HG; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Jang Y; Jeong MH; Kim HS; Hur SH; Rha SW; Lim DS; Her SH; Seung KB; Seong IW; Park SJ;
    JACC Cardiovasc Interv; 2012 Jul; 5(7):708-17. PubMed ID: 22814775
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery.
    Tsagalou E; Chieffo A; Iakovou I; Ge L; Sangiorgi GM; Corvaja N; Airoldi F; Montorfano M; Michev I; Colombo A
    J Am Coll Cardiol; 2005 May; 45(10):1570-3. PubMed ID: 15893168
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization.
    Kim YG; Park DW; Lee WS; Park GM; Sun BJ; Lee CH; Hwang KW; Cho SW; Kim YR; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Han S; Jung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    Am J Cardiol; 2012 Jun; 109(11):1548-57. PubMed ID: 22425329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
    Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
    Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Randomized trial of stents versus bypass surgery for left main coronary artery disease.
    Park SJ; Kim YH; Park DW; Yun SC; Ahn JM; Song HG; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Chung CH; Lee JW; Lim DS; Rha SW; Lee SG; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB
    N Engl J Med; 2011 May; 364(18):1718-27. PubMed ID: 21463149
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
    Raja SG; Benedetto U; Ilsley CD; Amrani M;
    Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: feasible and safe despite recurrent restenosis.
    Sillano D; Moretti C; Biondi-Zoccai G; Sheiban I
    Minerva Cardioangiol; 2008 Feb; 56(1):167-70. PubMed ID: 18432178
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus.
    Nishio K; Shigemitsu M; Kodama Y; Konno N; Katagiri T; Kobayashi Y
    Cardiovasc Revasc Med; 2009; 10(1):5-11. PubMed ID: 19159848
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.
    Kandzari DE; Leon MB; Meredith I; Fajadet J; Wijns W; Mauri L
    JACC Cardiovasc Interv; 2013 May; 6(5):504-12. PubMed ID: 23602459
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial.
    Lee JH; Kim HS; Lee SW; Park JH; Choi SW; Jeong JO; Cho Y; Lee N; Rhee KS; Ko JK; Seong IW
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):25-32. PubMed ID: 18412270
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Revascularization of left anterior descending artery with drug-eluting stents: comparison with off-pump surgery.
    Herz I; Moshkovitz Y; Hendler A; Adam SZ; Uretzky G; Ben-Gal Y; Mohr R
    Ann Thorac Surg; 2005 Jan; 79(1):88-92. PubMed ID: 15620921
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
    Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
    Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.
    Kuchulakanti PK; Chu WW; Torguson R; Clavijo L; Wolfram R; Mishra S; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2006 Jul; 98(2):187-92. PubMed ID: 16828590
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial).
    Waksman R; Ghali M; Goodroe R; Ryan T; Turco M; Ring M; McGarry T; Dobies D; Shammas N; Steinberg DH; Swymelar S; Kaneshige K; Torguson R
    Am J Cardiol; 2012 Oct; 110(8):1119-24. PubMed ID: 22762711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.